drugset / Trial / NCT01475578

Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

NCT01475578

Phase 2 Completed 240 enrolled Sinphar Pharmaceutical Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this phase II study of STA-1 capsule was to make preliminary evaluation on clinical efficacy and safety of STA-1 capsule in order that based on the dosage and study structure planned in this project, the dosage and study structure of phase III study can be confirmed.

Timeline

Start
2002-03
Primary completion
2002-10
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ERGOLOID Unknown 2 unknown Oral
Subject STA-1 Unknown 2 unknown Oral

Indications